Perceived appropriateness of alcohol screening and brief advice programmes in Colombia, Mexico and Peru and barriers to their implementation in primary health care - a cross-sectional survey.


Journal

Primary health care research & development
ISSN: 1477-1128
Titre abrégé: Prim Health Care Res Dev
Pays: England
ID NLM: 100897390

Informations de publication

Date de publication:
28 01 2021
Historique:
entrez: 28 1 2021
pubmed: 29 1 2021
medline: 21 9 2021
Statut: epublish

Résumé

Providing alcohol screening and brief advice (SBA) in primary health care (PHC) can be an effective measure to reduce alcohol consumption. To aid successful implementation in an upper middle-income country context, this study investigates the perceived appropriateness of the programme and the perceived barriers to its implementation in PHC settings in three Latin American countries: Colombia, Mexico and Peru, as part of larger implementation study (SCALA). An online survey based on the Tailored Implementation for Chronic Diseases (TICD) implementation framework was disseminated in the three countries to key stakeholders with experience in the topic and/or setting (both health professionals and other roles, for example regional health administrators and national experts). In total, 55 respondents participated (66% response rate). For responses to both appropriateness and barriers questions, frequencies were computed, and country comparisons were made using Chi square and Kruskal-Wallis non-parametric tests. Alcohol SBA was seen as an appropriate programme to reduce heavy alcohol use in PHC and a range of providers were considered suitable for its delivery, such as general practitioners, nurses, psychologists and social workers. Contextual factors such as patients' normalised perception of their heavy drinking, lack of on-going support for providers, difficulty of accessing referral services and lenient alcohol control laws were the highest rated barriers. Country differences were found for two barriers: Peruvian respondents rated SBA guidelines as less clear than Mexican (Mann-Whitney U = -18.10, P = 0.001), and more strongly indicated lack of available screening instruments than Colombian (Mann-Whitney U = -12.82, P = 0.035) and Mexican respondents (Mann-Whitney U = -13.56, P = 0.018). The study shows the need to address contextual factors for successful implementation of SBA in practice. General congruence between the countries suggests that similar approaches can be used to encourage widespread implementation of SBA in all three studied countries, with minor tailoring based on the few country-specific barriers.

Sections du résumé

BACKGROUND
Providing alcohol screening and brief advice (SBA) in primary health care (PHC) can be an effective measure to reduce alcohol consumption. To aid successful implementation in an upper middle-income country context, this study investigates the perceived appropriateness of the programme and the perceived barriers to its implementation in PHC settings in three Latin American countries: Colombia, Mexico and Peru, as part of larger implementation study (SCALA).
METHODS
An online survey based on the Tailored Implementation for Chronic Diseases (TICD) implementation framework was disseminated in the three countries to key stakeholders with experience in the topic and/or setting (both health professionals and other roles, for example regional health administrators and national experts). In total, 55 respondents participated (66% response rate). For responses to both appropriateness and barriers questions, frequencies were computed, and country comparisons were made using Chi square and Kruskal-Wallis non-parametric tests.
RESULTS
Alcohol SBA was seen as an appropriate programme to reduce heavy alcohol use in PHC and a range of providers were considered suitable for its delivery, such as general practitioners, nurses, psychologists and social workers. Contextual factors such as patients' normalised perception of their heavy drinking, lack of on-going support for providers, difficulty of accessing referral services and lenient alcohol control laws were the highest rated barriers. Country differences were found for two barriers: Peruvian respondents rated SBA guidelines as less clear than Mexican (Mann-Whitney U = -18.10, P = 0.001), and more strongly indicated lack of available screening instruments than Colombian (Mann-Whitney U = -12.82, P = 0.035) and Mexican respondents (Mann-Whitney U = -13.56, P = 0.018).
CONCLUSIONS
The study shows the need to address contextual factors for successful implementation of SBA in practice. General congruence between the countries suggests that similar approaches can be used to encourage widespread implementation of SBA in all three studied countries, with minor tailoring based on the few country-specific barriers.

Identifiants

pubmed: 33504413
pii: S1463423620000675
doi: 10.1017/S1463423620000675
pmc: PMC8057507
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e4

Subventions

Organisme : Medical Research Council
ID : MR/K02325X/1
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR300616
Pays : United Kingdom

Références

Rev Saude Publica. 2009 Aug;43 Suppl 1:51-61
pubmed: 19669065
Implement Sci. 2015 Apr 21;10:53
pubmed: 25895742
Subst Abuse Treat Prev Policy. 2016 Oct 28;11(1):37
pubmed: 27793173
Addiction. 2017 Feb;112 Suppl 2:23-33
pubmed: 28074571
J Interprof Care. 2005 May;19 Suppl 1:148-65
pubmed: 16096152
Am J Addict. 2011 Jul-Aug;20(4):343-56
pubmed: 21679266
BMC Med. 2014 Oct 21;12:182
pubmed: 25567363
Eur Respir J. 2017 Jul 13;50(1):
pubmed: 28705945
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Drug Alcohol Rev. 2010 Jul;29(4):437-45
pubmed: 20636661
BMJ Open. 2020 Jul 28;10(7):e038226
pubmed: 32723746
Alcohol Alcohol. 2014 Sep-Oct;49(5):531-9
pubmed: 25031247
Br J Cancer. 2015 Feb 3;112(3):580-93
pubmed: 25422909
JAMA Psychiatry. 2015 Aug;72(8):757-66
pubmed: 26039070
J Public Health (Oxf). 2011 Sep;33(3):412-21
pubmed: 21169370
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
Front Psychiatry. 2014 Nov 11;5:161
pubmed: 25426083
BMC Public Health. 2017 Jun 9;17(1):562
pubmed: 28599632
Alcohol Alcohol. 2017 Jan;52(1):56-64
pubmed: 27567270
Alcohol Alcohol. 2003 Nov-Dec;38(6):597-601
pubmed: 14633648
Lancet. 2018 Nov 17;392(10160):2214-2228
pubmed: 30314860
Alcohol Alcohol. 2004 Jul-Aug;39(4):351-6
pubmed: 15208170
J Addict Med. 2018 Jul/Aug;12(4):262-272
pubmed: 30063221
Alcohol Alcohol. 2018 May 1;53(3):326-332
pubmed: 29346480
Rev Lat Am Enfermagem. 2011 Jun;19 Spec No:813-20
pubmed: 21739064
Addiction. 2016 Nov;111(11):1935-1945
pubmed: 27237081
Lancet Public Health. 2020 Jan;5(1):e51-e61
pubmed: 31910980
BMC Health Serv Res. 2019 Mar 25;19(1):189
pubmed: 30909897
Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148
pubmed: 29476653
Trends Cardiovasc Med. 2017 Nov;27(8):534-538
pubmed: 28735784
BMJ Open. 2016 Aug 11;6(8):e011473
pubmed: 27515753
Implement Sci. 2013 Mar 23;8:35
pubmed: 23522377
Rev Peru Med Exp Salud Publica. 2016 Jul-Sep;33(3):432-437
pubmed: 27831605
Front Psychiatry. 2014 Aug 28;5:113
pubmed: 25221524
Subst Use Misuse. 2017 Feb 23;52(3):359-372
pubmed: 28001094
Alcohol Alcohol. 2014 Jan-Feb;49(1):66-78
pubmed: 24232177
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
Prev Sci. 2016 Aug;17(6):689-99
pubmed: 27167074
Subst Abus. 2015;36(3):281-8
pubmed: 25127073

Auteurs

Daša Kokole (D)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, 6200MD, Maastricht, The Netherlands.

Liesbeth Mercken (L)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, 6200MD, Maastricht, The Netherlands.

Eva Jané-Llopis (E)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, 6200MD, Maastricht, The Netherlands.
University Ramon Llull, ESADE, Barcelona, Spain.
Institute for Mental Health Policy Research, CAMH, Toronto, ONM5S 2S1, Canada.

Guillermina Natera Rey (G)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz México-Xochimilco 101, Huipulco, 14370Ciudad de México, Mexico.

Miriam Arroyo (M)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz México-Xochimilco 101, Huipulco, 14370Ciudad de México, Mexico.

Perla Medina (P)

Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz México-Xochimilco 101, Huipulco, 14370Ciudad de México, Mexico.

Augusto Pérez-Gómez (A)

Corporación Nuevos Rumbos, Bogotá, Colombia.

Juliana Mejía-Trujillo (J)

Corporación Nuevos Rumbos, Bogotá, Colombia.

Marina Piazza (M)

School of Public Health and Administration, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru.

Ines V Bustamante (IV)

School of Public Health and Administration, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru.

Amy O'Donnell (A)

Population Health Sciences Institute, Newcastle University, Newcastle upon TyneNE2 4AX, UK.

Eileen Kaner (E)

Population Health Sciences Institute, Newcastle University, Newcastle upon TyneNE2 4AX, UK.

Antoni Gual (A)

Red de Trastornos Adictivos, Instituto Carlos III, Sinesio Delgado, 4, 28029Madrid, Spain.
Addictions Unit, Psychiatry Department Hospital Clínic, Villarroel 170, 08036Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Rosselló, 08036Barcelona, Spain.

Hugo Lopez-Pelayo (H)

Red de Trastornos Adictivos, Instituto Carlos III, Sinesio Delgado, 4, 28029Madrid, Spain.
Addictions Unit, Psychiatry Department Hospital Clínic, Villarroel 170, 08036Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Rosselló, 08036Barcelona, Spain.

Bernd Schulte (B)

Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Jakob Manthey (J)

Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute for Clinical Psychology and Psychotherapy, TU Dresden, Chemnitzer Str. 46, 01187Dresden, Germany.

Jürgen Rehm (J)

Institute for Mental Health Policy Research, CAMH, Toronto, ONM5S 2S1, Canada.
Institute for Clinical Psychology and Psychotherapy, TU Dresden, Chemnitzer Str. 46, 01187Dresden, Germany.
Dalla Lana School of Public Health, University of Toronto, Toronto, ONM5T 3M7, Canada.
Department of Psychiatry, University of Toronto, Toronto, ONM5T 1R8, Canada.
Department of International Health Projects, Institute for Leadership and Health Management, I.M. Sechenov First Moscow State Medical University, 119992Moscow, Russian Federation.

Peter Anderson (P)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, 6200MD, Maastricht, The Netherlands.
Population Health Sciences Institute, Newcastle University, Newcastle upon TyneNE2 4AX, UK.

Hein de Vries (H)

Department of Health Promotion, CAPHRI Care and Public Health Research Institute, Maastricht University, 6200MD, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH